Southridge Capital Management
Required a courage in investing, not only that, the necessary experience, expertise and planning before taking action to make decisions and is a very large capital if we want the expected results.
Investments in technology, medicine / healthcare is an option that can provide a promising prospect. As performed by Southridge Partners II. This is a positive step from the policies made by the southridge advisors.
Stephen Hicks, Chairman and CEO of Southridge, LLC (“Southridge”), today announced that Southridge Partners II, an institutional investor, has entered into a $10 million equity purchase agreement with TechniScan, Inc. (OTC BB: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system.
TechniScan Medical Systems is a public medical device company engaged in the development and commercialization of automated ultrasound imaging systems. TechniScan automated imaging system is designed to assist clinicians in 3D breast imaging.
We are excited to be TechniScan’s equity investor in this major phase of developing better breast cancer diagnostics,” said Mr. Hicks. “Southridge is committed to working with TechniScan in the vital research of this emerging technology.”
Pursuant to a purchase agreement, TechniScan has the right, at its discretion, to sell to Southridge up to $10 million of its common stock over a 24-month period. The Company will have the right, but is not obligated, to sell stock to Southridge depending on certain conditions as set forth in the purchase agreement.
Required a courage in investing, not only that, the necessary experience, expertise and planning before taking action to make decisions and is a very large capital if we want the expected results.
Investments in technology, medicine / healthcare is an option that can provide a promising prospect. As performed by Southridge Partners II. This is a positive step from the policies made by the southridge advisors.
Stephen Hicks, Chairman and CEO of Southridge, LLC (“Southridge”), today announced that Southridge Partners II, an institutional investor, has entered into a $10 million equity purchase agreement with TechniScan, Inc. (OTC BB: TSNI), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system.
TechniScan Medical Systems is a public medical device company engaged in the development and commercialization of automated ultrasound imaging systems. TechniScan automated imaging system is designed to assist clinicians in 3D breast imaging.
We are excited to be TechniScan’s equity investor in this major phase of developing better breast cancer diagnostics,” said Mr. Hicks. “Southridge is committed to working with TechniScan in the vital research of this emerging technology.”
Pursuant to a purchase agreement, TechniScan has the right, at its discretion, to sell to Southridge up to $10 million of its common stock over a 24-month period. The Company will have the right, but is not obligated, to sell stock to Southridge depending on certain conditions as set forth in the purchase agreement.
Tidak ada komentar:
Posting Komentar